FDA approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs.
Anthim carries boxed warning that drug can cause allergic reactions, including a severe reaction called anaphylaxis.
Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
Medscape Medical News © WebMD, LLC
Heartwire © WebMD, LLC
WebMD Health News © WebMD, LLC
Reuters Health Information ©
Send comments and news tips to news@medscape.net.
